-
Signature
-
/s/ Sarah Dale, Attorney-in-Fact for Parker Harris
-
Stock symbol
-
CRM
-
Transactions as of
-
Sep 11, 2024
-
Transactions value $
-
-$273,421
-
Form type
-
4
-
Date filed
-
9/12/2024, 04:32 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
CRM |
Common Stock |
Options Exercise |
$245K |
+2.07K |
+1.76% |
$118.04 |
120K |
Sep 11, 2024 |
Direct |
F1 |
transaction |
CRM |
Common Stock |
Sale |
-$518K |
-2.07K |
-1.73% |
$250.00 |
118K |
Sep 11, 2024 |
Direct |
F1 |
holding |
CRM |
Common Stock |
|
|
|
|
|
947K |
Sep 11, 2024 |
By HJ Family Trust |
F2 |
holding |
CRM |
Common Stock |
|
|
|
|
|
116K |
Sep 11, 2024 |
By LLC BE |
F3 |
holding |
CRM |
Common Stock |
|
|
|
|
|
171K |
Sep 11, 2024 |
By LLC BN |
F3 |
holding |
CRM |
Common Stock |
|
|
|
|
|
116K |
Sep 11, 2024 |
By LLC NE |
F3 |
holding |
CRM |
Common Stock |
|
|
|
|
|
171K |
Sep 11, 2024 |
By LLC NN |
F3 |
holding |
CRM |
Common Stock |
|
|
|
|
|
116K |
Sep 11, 2024 |
By LLC ZE |
F3 |
holding |
CRM |
Common Stock |
|
|
|
|
|
171K |
Sep 11, 2024 |
By LLC ZN |
F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
CRM |
Non-qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2.07K |
-5.85% |
$0.00 |
33.4K |
Sep 11, 2024 |
Common Stock |
2.07K |
$118.04 |
Direct |
F1, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: